Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117381) titled 'Dose-Exposure Study of Icaritin Soft Capsules in Patients with Advanced Hepatocellular Carcinoma' on Jan. 23.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Jiangsu Provincial People's Hospital
Nanjing Tianyinshan Hospital
Condition:
hepatocellular carcinoma
Intervention:
Single-dose Administration Group:On Day 1 of the trial, subjects shall have breakfast in the morning and finish the meal within 30 minutes. The drug shall be taken 30 minutes after the meal: 600 mg (6 capsules) of Epimedium Extract Soft Capsules, administered with approximately 240 mL of warm water....